MedTrace Logo

Workplace Intervention Including Exercise and Nutrition in Obese Office Workers

NCT07603141 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-22

No results posted yet for this study

Summary

The main objective of this study is to investigate the efficacy of a 6-month workplace combined (exercise and nutrition) intervention in obese office workers, using a randomized controlled study. An additional objective of this study is to evaluate the individual responses per participant following the program.

Conditions

  • Obesity (BMI>30)

Interventions

OTHER

Workplace combined (exercise and nutrition) intervention

The IG will participate in a supervised 6-month combined intervention program (exercise and nutrition), which will take place inside the workplace settings during working hours. In more detail, the IG will participate, every working day (5 days/week), in a 6-month supervised combined chair-based exercise program (120 training sessions; 25-40 min/day), including chair based seated and chair-assisted standing exercises to improve flexibility, balance, strength and aerobic capacity. Except exercise, the intervention program consisted of weekly counseling and educational activities in healthy diet and proper hydration using presentations, leaflets, individual and group sessions with nutritionist, use of applications for proper hydration, use of goal-setting cards for healthy options

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Konstantina Karatrantou · University of Thessaly

  • Vassilis Gerodimos · University of Thessaly

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-07-30
Completion
2027-02-28

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07603141 on ClinicalTrials.gov